• Insights
    • Webinars
    • Blog
    • Perspectives
    • Toolboxes
    • Events
    • Awards
  • Offering
    • Academy
      • Innovation courses
      • Innovation programs
    • Consulting
      • Onsite consultants
      • Project management
    • Services
      • Scout it
        • Business & strategy
        • Technology management
      • Invent it
        • Proposition management
        • Feasibility & IP development
      • Create it
        • Strategic design
        • Demonstrators & prototypes
      • Scale it
        • Go-to-market
        • Industrialization & production
    • Funding
      • Innovation grants
      • Seed capital
      • Subsidy applications
    • Solutions
      • MyStartUp
      • MyStartUp Portfolio
      • MyInnovationFactory
      • MyInnovationTalent
      • MyFutureProduct
  • Markets
    • Smart Space & Security
    • Smart FMCG
    • Smart Life Sciences
    • Smart Industry
  • Capabilities
    • Strategic Innovation
      • OpenLab
      • DesignLab
      • InnoLab
    • Digital innovation
      • AILab
      • DigitalLab
      • EmbeddedLab
    • Product innovation
      • MechLab
      • PhysicsLab
      • FabLab
    • High-tech innovation
      • OpticsLab
  • Technologies
    • Technology portfolio
    • IoT & sensors
    • AI & data science
    • Robotics & autonomy
    • Cooling, heating & fluidics
  • About
    • Our story
    • News
  • Jobs
  • Contact
Verhaert Masters in InnovationVerhaert Masters in Innovation
Verhaert Masters in InnovationVerhaert Masters in Innovation
  • Insights
        • Insights

        • Perspectives
        • Blog
        • Webinars
        • Toolboxes
        • Awards
  • Offering
        • Services

        • Consulting

        • Academy

        • Funding

        • Solutions

        • Scout it
          • Business & strategy
          • Technology management
        • Invent it
          • Proposition management
          • IP management & feasibility
        • Create it
          • Strategic design
          • Demonstrators & prototypes
        • Scale it
          • Go-to-market
          • Industrialization & production
        • Onsite consultants
        • Project management
        • Innovation courses
        • Innovation programs
        • Subsidy applications
        • Seed capital
        • Innovation grants
        • MyStartUp
          • Boost your venture
          • Find your incubation program
          • MyStartUp Portfolio
        • MyInnovationFactory
          • Adjacent innovation for corporates
        • MyInnovationTalent
          • Boost your innovation capacity with on-site consultants
        • MyFutureProduct
          • Make your product smart & future-proof
  • Markets
        • Smart Space & Security

        • Microgravity
          Earth observation
          Navigation
          Exploration
          Security
        • Smart FMCG

        • Dispensers
          Cooling & heating
          Servers
          Smart packaging
          Vending equipment
        • Smart Life Sciences

        • MedTech
          BioTech
          HealthTech
          Ophthalmic
        • Smart Industry

        • Mobility & logistics
          Chemical & material
          Home, building & construction
          Manufacturing & equipment
          Energy
  • Capabilities
        • Strategic innovation

        • OpenLab
        • DesignLab
        • InnoLab
        • Digital innovation

        • DigitalLab
        • AILab
        • EmbeddedLab
        • Product innovation

        • MechLab
        • PhysicsLab
        • FabLab
        • High-tech innovation

        • OpticsLab
  • Technologies
        • Technologies

        • IoT & sensors
        • AI & data science
        • Robotics & autonomy
        • Cooling, heating & fluidics
        • Portfolio

  • About
        • About

        • News
        • Our story
  • Jobs
  • Contact

The role of technology in our defense against infectious diseases

30 June 2022 Posted by Michiel Twisk My Technology, Perspectives, Product innovation, Smart Life Sciences

Since 2019, the world has been gripped by SARS-COV-2 and its various mutations. Societies worldwide have demonstrated resilience, especially healthcare workers, scientists and all whom created the ‘New Normal’ that allowed us to continue our lives as good as possible. Even though it feels like the storm has passed, we need to continue to innovate. We need to innovate to lessen the burden of new waves and to be more resilient to new mutations and viruses. What’s the role of technology in our defense against infectious diseases?

Perspective the role of technology in our defense against infectious diseases

Innovations such as the mRNA vaccines have already made significant impact in the current pandemic, and hold an unprecedented potential to a broad range of diseases. For example through self-amplifying RNA vaccines to prolong its efficacy, or mRNA cocktails to protect against existing or predicted mutations. What else could we want? What’s the role of technology? Let’s have a look.

Can we get rid of that painful intramuscular injection?

Or freeing up all those healthcare workers setting jabs day-in, day-out? An exciting new move is seen in the development of nasal spray vaccines delivery and drugs that may temporarily boost our resistance against viral infections. Currently, ten nasally delivered vaccines are undergoing, or recruiting for, phase 1 clinical trials. We’re not there yet. Even though the administration is much more convenient and user friendly, with the potential of decentralizing the complete distribution of vaccines, it comes with its challenges. Unfortunately, our bodies innate immune system isn’t helping, our natural defense mechanism causes some issues. One particular issue is that we actively clear the vaccines or drugs through mucociliary clearance, or snot.

Can we boost our resistance against viral infections temporarily?

What would that imply? Effectively, several studies have shown that nasally administered drugs or compounds create an additional barrier of defense reducing infectiousness of viruses drastically. These drugs may act by locally activating or ‘boosting’ the innate immune system, or by blocking the ‘entry-points’ of the virus on our cells. Interestingly, in mice studies, a drug showed effective protection against SARS-CoV-2 infection pre- and post exposure, with drug administered 8 hours post exposure.

Download the perspective to read more on how the role of technology in innovations may be the key to enable the full potential of medicinal innovations.

Tags: Medical innovation
Share
5

About Michiel Twisk

This author hasn't written their bio yet.
Michiel Twisk has contributed 7 entries to our website, so far.View entries by Michiel Twisk

You also might be interested in

Featured image - Medical blogpost 2

Focusing patient treatment on prevention & personalization

Feb 10, 2021

MedTech companies can transform patient treatment by focusing on prevention and personalization instead of illnesses.

Choose between a native & hybrid app development platform

Choose between a native & hybrid app development platform

Jan 18, 2021

To develop a medical app, the choice between a native & hybrid platform can be a dilemma. 5 key elements for a decision-making framework.

Featured image - Smart Medical Blogpost 1

Rebuilding MedTech innovation companies

Feb 1, 2021

A person’s health is priceless. How can medical device companies turn rapidly changing technologies and user needs into new values.

OTHER CONTENT
  • Navigating the future of the maritime industry
  • Digital innovation: the game changer in uncertain times
  • Cost-efficient, compact & insightful: 6 must-have smart sensors for your FMCG appliance
NEWSLETTER



Verhaert Masters in Innovation is a pioneering innovation group helping companies and entrepreneurs to innovate, creating new products, businesses and services.

Verhaert icon LinkedIn Verhaert icon Facebook Verhaert icon SlideShare Verhaert icon YouTube Verhaert icon Twitter

SERVICES
FUNDING
SOLUTIONS
MARKETS
CAPABILITIES
TECHNOLOGY
PERSPECTIVES
BLOGS
WEBINARS
ABOUT
NEWS
JOBS
CONTACT

© 2023 Verhaert New Products & Services NV • BE 0439.039.420 • Privacy policy • Terms of use

Prev Next